BubbleFect Therapeutic Platform

About PartitionBio

PartitionBio is an early-stage biotechnology company pioneering a next-generation, non-viral delivery platform based on engineered biomolecular condensates. Its flagship product, BubbleFect, is designed as a simple, stable, and versatile reagent for the intracellular delivery of large macromolecules, targeting critical bottlenecks in research, drug discovery, and ultimately, genetic medicine. The company's mission is to democratize access to advanced therapies by reducing the cost and complexity of delivery, with initial focus on enabling faster research and scalable gene therapy development. Its platform holds potential across functional genomics, CRISPR editing, and therapeutic delivery applications.

Therapeutic Areas